Home » Topics » Regulatory

Regulatory
RSS

Sanofi-Synthelabo begins rolling out Xatral XL in Europe

April 18, 2000

Enbrel recommended by FDA advisory committee for early RA

April 17, 2000

SangCya approved in Germany

April 12, 2000

Apligraf PMA supplement tentatively scheduled for FDA review in May

April 11, 2000

New formulation of Hectorol approved by FDA

April 11, 2000

Bayer obtains first approval worldwide for new antiallergic agent

April 11, 2000

FDA gives go-ahead for Access to commence OraDisc clinical trials

April 5, 2000

Another indication for Enbrel will be discussed at advisory committee meeting

April 5, 2000

CollaGenex seeks FDA approval for new dosage form of Periostat

April 5, 2000

Avandia receives FDA approval for treatment of type II diabetes in combination with sulfonylureas

April 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...